FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Liu Zhijing CBPO 		2. Issuer Name and Ticker or Trading Symbol

China Biologic Products, Inc. [ CBPO ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
Corporate Vice President
(Last)          (First)          (Middle)

18TH FLOOR, JIALONG INTERNATIONAL, BUILDING, 19 CHAOYANG PARK ROAD 		3. Date of Earliest Transaction (MM/DD/YYYY)

5/8/2017
(Street)

BEIJING, F4 100125
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   5/8/2017     M (1)    6358   (1) A $9.85   10969   D    
Common Stock   5/8/2017     S (2)    6358   (2) D $116.68   (5) 4611   D    
Common Stock   5/9/2017     M (3)    1142   (3) A $9.85   5753   D    
Common Stock   5/9/2017     S (4)    1142   (4) D $115.40   (6) 4611   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy)   (7) $9.85   5/8/2017     M         6358    9/1/2016   8/31/2022   Common Stock   6358     (7) 1142   D    
Stock Option (right to buy)   (7) $9.85   5/9/2017     M         1142    9/1/2016   8/31/2022   Common Stock   1142     (7) 0   D    

Explanation of Responses:
(1)  Represents 6,358 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
(2)  Represents 6,358 shares of common stock sold on the open market at a weighted average price of $116.68 per share on May 8, 2017.
(3)  Represents 1,142 shares of common stock acquired by the Reporting Person through the exercise of stock options to purchase the Issuer's common stock. See Footnote 7 below for further details on the relevant stock options.
(4)  Represents 1,142 shares of common stock sold on the open market at a weighted average price of $115.40 per share on May 9, 2017.
(5)  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $116.62 to $116.95, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 5.
(6)  The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions in the open market at prices ranging from $115.20 to $115.65, inclusive. The Reporting Person undertakes to provide to any security holders of the Issuer or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this Footnote 6.
(7)  Represents previously reported stock options to purchase 15,000 shares of the Issuer's common stock, granted to the Reporting Person under the Issuer's 2008 equity incentive plan, pursuant to a stock option agreement dated August 31, 2012. The options were vested annually over a 4-year period in four equal portions, with the initial vesting date being September 1, 2013.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Liu Zhijing CBPO
18TH FLOOR, JIALONG INTERNATIONAL
BUILDING, 19 CHAOYANG PARK ROAD
BEIJING, F4 100125

Corporate Vice President

Signatures
/s/ Liu Zhijing 5/10/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more China Bioligic Products Charts.
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more China Bioligic Products Charts.